Conference Coverage (12th World AIDS)
Most Cost-Effective U.S. Technology: AIDS Drugs
Published in Vaccine Weekly, September 7th, 1998
Highly active antiretroviral therapy (HAART) - now the standard of care for the industrialized world - has greatly reduced AIDS incidence. And while HAART isn't cheap, its cost is far less than the cost of treating AIDS.
"HAART is arguably the most cost-effective major new medical technology that has been introduced in the past decade," say John G. Bartlett and colleagues.
The Johns Hopkins researchers reported the results of a cost/effect study of HAART in clinical practice at the 12th World AIDS Conference, held June 28-July 3, 1998, in Geneva, Switzerland.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (1998-09-07)
More Articles from Vaccine Weekly
- Conference Coverage (12th World AIDS)
HIV (beta)-Chemokine Levels Aid AIDS Vaccines - Conference Coverage (12th World AIDS)
Gallo: Too Soon To Focus Solely on AIDS Vaccine - Conference Coverage (12th World AIDS)
Hypertension May Limit New AIDS Therapy Approach - Conference Coverage (12th World AIDS)
New HIV Trick: Immunization Against Antiviral Chemokines - Conference Coverage (12th World AIDS)
Uninfected Sex Workers Yield Clues to AIDS Vaccine - Conference Coverage (12th World AIDS)
Vaccination With HIV DNA Induces Anti-HIV Chemokines - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
